期刊文献+

3株耐碳青霉烯鲍曼不动杆菌临床株耐药机制的研究 被引量:4

The mechanism of three carbapenem-resistant clinical isolates of Acinetobacter baumannii
下载PDF
导出
摘要 目的研究鲍曼不动杆菌(Acinetobacter baumannii)对碳青霉烯耐药的分子机制。方法采用琼脂纸片扩散法(KB法)及微量肉汤法筛选出3株对碳青霉烯耐药的鲍曼不动杆菌临床株,PCR扩增blaOXA-23基因和测序、提取外膜蛋白及进行聚丙烯酰胺凝胶电泳(SDS-PAGE)。结果3株耐碳青霉烯的鲍曼不动杆菌具有多重耐药性;耐药基因PCR扩增和测序证实3株耐药菌均有blaOXA-23基因;其中1株耐药菌AB173的外膜蛋白电泳条带在28.8ku处出现明显缺失,其余2株耐药菌在该条带处与敏感菌相比较无明显差异。结论本次试验中对碳青霉烯耐药的鲍曼不动杆菌全部含有blaOXA-23基因,其中一株耐药菌还出现了外膜蛋白孔道的缺失可能与其多重耐药性有关。 Objective To study the molecular mechanism of carbapenem-resistant Acinetobacter baumannnii. Methods The carbapenem-resistant strains were detected from clinical isolatesAcinetobacter baumannii by disk diffusion and micro-diluted broth method. The b/aoxA-23 gene was amplified by PCR method and then sequenced. Their out membrane proteins (OMP) were extracted and analyzed by using SDS-polyacry- lamide gel electrophoresis and a carbapenem-susceptible Acinetobacter baumannnii strain as control. Results The PCR amplification and sequencing results showed that the three multi-resiltant Acinetobacter baurnannii isolates were multi-resistant and all carried blaoxA-23 gene. The SDS-PAGE electrophoresis result showed that 28. 8ku-band deficiency was found in A. baurnannii AB173, whereas other two resistant isolates showed the same electrophoresis profiles with the control. Conclusions In this experiment, all three carbapenem-resistant Acinetobacter baumannii strains carried blaoxA-23 gene and one of them lacked a 28.8ku OMP, which were probably attributed to the multi-resistance of organisms.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2007年第6期377-380,共4页 Chinese Journal of Antibiotics
关键词 鲍曼不动杆菌 多重耐药 blaOXA-23基因 外膜蛋白 聚合酶链反应 Acinetobacter baumannii Multi-resistance blaoxA-23 gene Outer membrane protein Polymerase chain reaction (PCR)
  • 相关文献

参考文献10

  • 1Bergogne-Berezin E,Towner K J.Acinetobacter spp.as nosocomial pathogens:microbiological,clinical,and epidemiologieal features[J].Clin Microbiol Rev,1996,9(2):148
  • 2Donald H M,Scaife W,Amyes S G,et al.Sequence analysis of ARI-1,a novel OXA β-lactamase,responsible for imipenem resistance in Acinetobacter baumannii 6892[J].Antimicrob Agents Chemother,2000,44(1):196
  • 3Mussi M A,Limansky A S,Viale A M.Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii:natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins[J].Antimicrob Agents Chernother,2005,49(4):1432
  • 4Bou G,Cervero G,Dominguez M A,et al.Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:high-level carbapenem resistance in A.baumannii is not due solely to the presence of betalactamases[J].J Clin Microbiol,2000,38(9):3299
  • 5Tankovie J,Legrand P,De Gatines G,et al.Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods[J].J Clin Microbiol,1994,32(11):2677
  • 6张永,唐英春,陆坚,张扣兴.鲍曼不动杆菌对亚胺培南耐药分子机制的研究[J].中国抗生素杂志,2005,30(4):217-221. 被引量:71
  • 7Fernandez-Cuenca F,Martinez-Martinez L,Conejo M C,et al.Relationship between beta-lactamase production,outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii[J].J Antimicrob Chemother,2003,51(3):565
  • 8Wahher-Rasmussen J.Hoiby N.OXA-type carbapenemases[J].J Antimicrob Chemother,2006,57(3):373
  • 9李蓉,李文林,石小玉,梁朝,赵林,廖晚珍,徐小文,崔伟光.产ESBLs鲍曼不动杆菌的耐药特性、质粒谱及耐药基因型[J].中国抗生素杂志,2006,31(4):202-205. 被引量:25
  • 10Nikaido H.Molecular basis of bacterial outer membrane permeability revisited[J].Microbiol Mol Biol Rev,2003,67(4):593

二级参考文献21

  • 1宗志勇,吕晓菊,高燕渝,俞汝佳.产金属β-内酰胺酶的鲍氏不动杆菌在我国内地出现(英文)[J].中国抗生素杂志,2004,29(10):603-606. 被引量:12
  • 2Jain R, Danziger L H. Multidrug-resistant acinetobacter infections: an emerging challenge to clinicians [J]. Ann Pharmacother, 2004,38(9): 1449.
  • 3Brown S, Bantar C, Young H K, et al. Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2[J]. Lancet, 1998,351 (9097): 186.
  • 4Weinbren M J, Johnson A P, Kaufmann M E, et al.Acinetobacter spp isolates with reduced susceptibilities to carbapenems in a UK burns unit [J]. J Antimicrob Chemother, 1998,41(5) :574.
  • 5Quale J, Bratu S, Landman D, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City [J]. Clin Infect Dis, 2003,37 (2): 214.
  • 6Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes [J]. Clin Microbiol Infect,2002,8(6):321.
  • 7Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-beta- lactamase- producing gram-negative bacteria by using thiol compounds [J]. J Clin Microbiol, 2000,38 (1): 40.
  • 8Afzal-Shah M, Woodford N, Livermore D M. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].Antinicrob Agents Chemother , 2001,45 (2): 583.
  • 9Donald H M, Scaife W, Amyes S G B, et al. Sequence analysis of ARI-1, a novel OXA b-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92[J]. Antimicrob Agents Chemother, 2000,44 (1):196.
  • 10Naas T, Nordmann P. OXA-type beta-lactamases [J].Curr Pharm Des,1999,5(11):865.

共引文献91

同被引文献76

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部